Kezar Life Sciences, Inc. (KZR)

NASDAQ: KZR · Real-Time Price · USD

6.23

-0.08 (-1.27%)

At close: Oct 21, 2025, 4:00 PM EDT

6.24

+0.01 (0.16%)

After-hours: Oct 21, 2025, 7:07 PM EDT

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
Immune-mediated Diseases and Cancer Therapeutics	7.00M

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
United States	7.00M